Health Condition 1: null- Breast Cancer
Conditions
Interventions
Intervention1: Paravertebral block with ropivacaine with dexmedetomidine: 0.75% ropivacaine 18ml with 1 mcg/kg dexmedetomidine single site unilateral presurgical paravertebral block
Intervention2: par
Sponsors
Sangeeta Chakraborty
Eligibility
Inclusion criteria
Inclusion criteria: ASA I & II
Exclusion criteria
Exclusion criteria: 1. Patients who refrained from giving an informed consent 2. Those with spinal or chest wall deformity and/or local infection at site of block. 3. Patients with coagulopathy 4. Patients with hypersensitivity to either ropivacaine or dexmedetomidine 5. Patient who had cognitive abnormalities due to underlying psychiatric comorbidities or patients who were not cooperative. 6. Heart block, moderate or severe stenotic/regurgitant heart lesions. 7. Patient with BMI 30, height 195 cm .
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Post operative analgesia intensity and durationTimepoint: Just after the end of the surgery and then 4 hourly till 24 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| Heart rate, Mean Arterial Pressure, Spo2, side effects, complications, patient satisfactionTimepoint: Intraoperatively and just after the end of the surgery and then 4 hourly upto 24 hours | — |
Countries
India
Contacts
Public ContactDr Rajesh Raman
King George Medical University
Outcome results
None listed